Psoriasis Market to Exhibit Rapid Growth Rate During the Forecast Period (2022-2032), Investigates DelveInsight | Key Companies - Bristol Myers Squibb, Arcutis Biotherapeutics, AbbVie, Immunex Corporation, Monitor CRO, Samsung Bioepis Co.

DelveInsight's "Psoriasis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Psoriasis, historical and forecasted epidemiology as well as the Psoriasis market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

To Know in detail about the Psoriasis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Psoriasis Market Forecast
https://www.delveinsight.com/report-store/psoriasis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Psoriasis Market Report:
• The Psoriasis market size was valued approximately USD 14 Billion in 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• By 2032, there will be 17,373,980 cases of psoriasis overall in the seven key markets, according to Delveinsight's projections
• In 2021, there were 15,100,161 adult instances of psoriasis and 273,911 paediatric cases of the 7MM widespread condition. In 2021, the majority of psoriasis cases were found in the US
• With 2,717,248 cases, Germany had the highest prevalence of psoriasis among the European nations, followed by Italy, which had 1,525,203 cases in 2021
• Aside from the Psoriasis treatments already mentioned, there are a few oral candidates in the Phase II stage of clinical development, including BI 730357 (Boehringer Ingelheim), JTE-451 (Akros Pharma Inc.), KD025 (Kadmon Pharmaceuticals), PF- 06826647 (Pfizer), and XP23829 (Arbour Pharmaceuticals/Dr. Reddy's Laboratories)
• Key Psoriasis Companies: Bristol Myers Squibb, Arcutis Biotherapeutics, AbbVie, Immunex Corporation, Monitor CRO, Samsung Bioepis Co., Ltd., MetrioPharm AG, Almirall, S.A., GlaxoSmithKline, Amgen, Therapeutics, Inc., Boehringer Ingelheim, Avillion LLP, and others
• Key Psoriasis Therapies: Deucravacitinib, ARQ-151, ABBV-157, Methotrexate, GN037, Humira (Adalimumab), MP1032, LAS41004, Calcipotriene Foam, U0267, Etanercept, PTH (1-34), risankizumab, M1095 (Sonelokimab), and others
• The Psoriasis epidemiology based on gender analyzed that psoriasis affects both males and females equally
• The Psoriasis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Psoriasis pipeline products will significantly revolutionize the Psoriasis market dynamics.

Psoriasis Overview
Psoriasis is a chronic, immune-mediated inflammatory skin condition that most frequently affects the scalp, lower back, elbows, and knees. It can also affect other parts of the body.

Get a Free sample for the Psoriasis Market Report
https://www.delveinsight.com/sample-request/psoriasis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Psoriasis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Psoriasis Epidemiology Segmentation:
The Psoriasis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Psoriasis
• Prevalent Cases of Psoriasis by severity
• Gender-specific Prevalence of Psoriasis
• Diagnosed Cases of Episodic and Chronic Psoriasis

Download the report to understand which factors are driving Psoriasis epidemiology trends @ Psoriasis Epidemiology Forecast
https://www.delveinsight.com/sample-request/psoriasis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Psoriasis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Psoriasis market or expected to get launched during the study period. The analysis covers Psoriasis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Psoriasis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Psoriasis Therapies and Key Companies
• Deucravacitinib: Bristol Myers Squibb
• ARQ-151: Arcutis Biotherapeutics
• ABBV-157: AbbVie

Discover more about therapies set to grab major Psoriasis market share @ Psoriasis Treatment Market
https://www.delveinsight.com/sample-request/psoriasis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Psoriasis Market Drivers
• Important progress has been made regarding understanding disease pathology, diagnosis, and treatment effects in Psoriasis.
• Population rates of Psoriasis in children and young people have been investigated in several countries
• Many therapies are under investigation in various phases of clinical trials

Psoriasis Market Barriers
• Identify and synthesize recent research findings in the etiology and psychological treatment of Psoriasis
• Due to patients' poor quality of life with Psoriasis, there is significant patient willingness towards expensive therapies

Scope of the Psoriasis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Psoriasis Companies: Bristol Myers Squibb, Arcutis Biotherapeutics, AbbVie, Immunex Corporation, Monitor CRO, Samsung Bioepis Co., Ltd., MetrioPharm AG, Almirall, S.A., GlaxoSmithKline, Amgen, Therapeutics, Inc., Boehringer Ingelheim, Avillion LLP, and others
• Key Psoriasis Therapies: Deucravacitinib, ARQ-151, ABBV-157, Methotrexate, GN037, Humira (Adalimumab), MP1032, LAS41004, Calcipotriene Foam, U0267, Etanercept, PTH (1-34), risankizumab, M1095 (Sonelokimab), and others
• Psoriasis Therapeutic Assessment: Psoriasis current marketed and Psoriasis emerging therapies
• Psoriasis Market Dynamics: Psoriasis market drivers and Psoriasis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Psoriasis Unmet Needs, KOL's views, Analyst's views, Psoriasis Market Access and Reimbursement

To know more about Psoriasis companies working in the treatment market, visit @ Psoriasis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/psoriasis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Psoriasis Market Report Introduction
2. Executive Summary for Psoriasis
3. SWOT analysis of Psoriasis
4. Psoriasis Patient Share (%) Overview at a Glance
5. Psoriasis Market Overview at a Glance
6. Psoriasis Disease Background and Overview
7. Psoriasis Epidemiology and Patient Population
8. Country-Specific Patient Population of Psoriasis
9. Psoriasis Current Treatment and Medical Practices
10. Psoriasis Unmet Needs
11. Psoriasis Emerging Therapies
12. Psoriasis Market Outlook
13. Country-Wise Psoriasis Market Analysis (2019-2032)
14. Psoriasis Market Access and Reimbursement of Therapies
15. Psoriasis Market Drivers
16. Psoriasis Market Barriers
17. Psoriasis Appendix
18. Psoriasis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Psoriasis Pipeline https://www.delveinsight.com/report-store/psoriasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Psoriasis Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Psoriasis market. A detailed picture of the Psoriasis pipeline landscape is provided, which includes the disease overview and Psoriasis treatment guidelines.
Psoriasis Epidemiology https://www.delveinsight.com/report-store/psoriasis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Psoriasis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Psoriasis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Scedosporium Infection Market https://www.delveinsight.com/report-store/scedosporium-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Scedosporium Infection Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Scedosporium Infection, historical and forecasted epidemiology as well as the Scedosporium Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Vascular Graft Devices Market https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2027 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Vascular Stents Market https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2027 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.

Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2027" report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Bladder Scanners Market https://www.delveinsight.com/report-store/bladder-scanners-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2027" report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Media Contact

Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.